Dr. Pranabh Shrestha, MD

Dr. Shrestha practices at PeaceHealth Southwest Medical Center in Vancouver, Washington, part of PeaceHealth.

Dr. Shrestha's NPI, 1598085490, was assigned on June 3, 2010. Dr. Shrestha holds Idaho license M-14643.

Dr. Shrestha's primary practice is PeaceHealth Southwest Medical Center, at 400 NE Mother Joseph Place, Vancouver, WA 98664 in Clark County. The practice phone is (360) 256-2000.

Dr. Shrestha's primary practice is PeaceHealth Southwest Medical Center in Vancouver, Washington, part of PeaceHealth. Dr. Shrestha is also affiliated with Gritman Medical Center. The medical group on file is PeaceHealth Medical Group. Dmand AI also links Dr. Shrestha to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrestha practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Shrestha's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Shrestha's licenses on file in 2 states: Idaho and Washington.

CMS data shows 1,380 Medicare services from Dr. Shrestha across 16 procedure codes in 2024, for 507 Medicare patients. Medicare paid $113,589 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 507 Medicare patients who saw Dr. Shrestha in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrestha's median patient age at 70, with 51% women.

In 2024, Dr. Shrestha wrote 848 Medicare Part D claims for 204 patients. 32% of them were for generic drugs. CMS names the drug for 717 of them, across 18 drugs with 11 or more claims each, at $363,000 in total drug cost. In 2023, CMS named 1,642 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Shrestha for performance year 2024, reported through an alternative payment model (APM). Dr. Shrestha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shrestha as offering telehealth.

Dmand AI links 3 papers to Dr. Shrestha, published from 2011 to 2014. Dr. Shrestha's most frequent co-authors are Marc Adelman, MD, Mohammad Hassan Alsumrain, MD and Javier Fernando Dieguez, MD.

CMS Open Payments shows 52 general payments to Dr. Shrestha from 9 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $387.